These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 32359820)

  • 1. Association of HLA Typing and Alloimmunity With Posttransplantation Membranous Nephropathy: A Multicenter Case Series.
    Batal I; Vasilescu ER; Dadhania DM; Adel AA; Husain SA; Avasare R; Serban G; Santoriello D; Khairallah P; Patel A; Moritz MJ; Latulippe E; Riopel J; Khallout K; Swanson SJ; Bomback AS; Mohan S; Ratner L; Radhakrishnan J; Cohen DJ; Appel GB; Stokes MB; Markowitz GS; Seshan SV; De Serres SA; Andeen N; Loupy A; Kiryluk K; D'Agati VD
    Am J Kidney Dis; 2020 Sep; 76(3):374-383. PubMed ID: 32359820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phospholipase A2 receptor positive membranous nephropathy long after living donor kidney transplantation between identical twins.
    Saito H; Hamasaki Y; Tojo A; Shintani Y; Shimizu A; Nangaku M
    Nephrology (Carlton); 2015 Jul; 20 Suppl 2():101-4. PubMed ID: 26031599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. De novo membranous nephropathy (MN) in kidney allografts. A peculiar form of alloimmune disease?
    Ponticelli C; Glassock RJ
    Transpl Int; 2012 Dec; 25(12):1205-10. PubMed ID: 22909324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Membranous Nephropathy Posttransplantation: An Update of the Pathophysiology and Management.
    Leon J; Pérez-Sáez MJ; Batal I; Beck LH; Rennke HG; Canaud G; Legendre C; Pascual J; Riella LV
    Transplantation; 2019 Oct; 103(10):1990-2002. PubMed ID: 31568231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of de novo HLA donor specific antibodies (HLA-DSA), HLA antibodies (HLA-Ab) and allograft rejection post blood transfusion in kidney transplant recipients.
    Jalalonmuhali M; Carroll RP; Tsiopelas E; Clayton P; Coates PT
    Hum Immunol; 2020 Jul; 81(7):323-329. PubMed ID: 32327243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA-DR, and not PLA2R, is expressed on the podocytes in kidney allografts in de novo membranous nephropathy.
    Wen J; Xie K; Zhang M; Chen J; Zhang J; Cheng D; Li X; Ji S; Liu Z
    Medicine (Baltimore); 2016 Sep; 95(37):e4809. PubMed ID: 27631233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. De Novo Membranous Nephropathy Associated With Antibody-Mediated Rejection in Kidney Transplant Recipients.
    de Sousa MV; Fernandes LGR; de Freitas LLL; Zollner RL; Mazzali M
    Transplant Proc; 2022 Jun; 54(5):1270-1277. PubMed ID: 35287969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiphospholipase A2 Receptor Antibody Levels Predict the Risk of Posttransplantation Recurrence of Membranous Nephropathy.
    Quintana LF; Blasco M; Seras M; Pérez NS; López-Hoyos M; Villarroel P; Rodrigo E; Viñas O; Ercilla G; Diekmann F; Gómez-Roman JJ; Fernandez-Fresnedo G; Oppenheimer F; Arias M; Campistol JM
    Transplantation; 2015 Aug; 99(8):1709-14. PubMed ID: 25675198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrent and de novo glomerulonephritis following renal transplantation: higher rates of rejection and lower graft survival.
    Mirioglu S; Caliskan Y; Goksoy Y; Gulcicek S; Ozluk Y; Sarihan I; Seyahi N; Kilicaslan I; Turkmen A; Sever MS
    Int Urol Nephrol; 2017 Dec; 49(12):2265-2272. PubMed ID: 29039058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is
    Darji PI; Patel HA; Darji BP; Sharma A; Halawa A
    World J Transplant; 2022 Jan; 12(1):15-20. PubMed ID: 35096553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoantibodies specific for the phospholipase A2 receptor in recurrent and De Novo membranous nephropathy.
    Debiec H; Martin L; Jouanneau C; Dautin G; Mesnard L; Rondeau E; Mousson C; Ronco P
    Am J Transplant; 2011 Oct; 11(10):2144-52. PubMed ID: 21827616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of membranous nephropathy recurrence after transplantation by monitoring of anti-PLA2R1 (M-type phospholipase A2 receptor) autoantibodies: a case series of 15 patients.
    Seitz-Polski B; Payré C; Ambrosetti D; Albano L; Cassuto-Viguier E; Berguignat M; Jeribi A; Thouret MC; Bernard G; Benzaken S; Lambeau G; Esnault VL
    Nephrol Dial Transplant; 2014 Dec; 29(12):2334-42. PubMed ID: 25063424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The association of acute rejection vs recurrent glomerular disease with graft outcomes after kidney transplantation.
    Singh T; Astor BC; Zhong W; Mandelbrot DA; Maursetter L; Panzer SE
    Clin Transplant; 2019 Dec; 33(12):e13738. PubMed ID: 31630440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-phospholipase A₂ receptor antibodies in recurrent membranous nephropathy.
    Kattah A; Ayalon R; Beck LH; Sethi S; Sandor DG; Cosio FG; Gandhi MJ; Lorenz EC; Salant DJ; Fervenza FC
    Am J Transplant; 2015 May; 15(5):1349-59. PubMed ID: 25766759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eplet Mismatch Load and
    Senev A; Coemans M; Lerut E; Van Sandt V; Kerkhofs J; Daniëls L; Driessche MV; Compernolle V; Sprangers B; Van Loon E; Callemeyn J; Claas F; Tambur AR; Verbeke G; Kuypers D; Emonds MP; Naesens M
    J Am Soc Nephrol; 2020 Sep; 31(9):2193-2204. PubMed ID: 32764139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of de novo and recurrent membranous nephropathy in renal transplant patients.
    Poduval RD; Josephson MA; Javaid B
    Semin Nephrol; 2003 Jul; 23(4):392-9. PubMed ID: 12923728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Remission of de novo membranous nephropathy in a kidney allograft recipient: a case report.
    Okyay GU; Inal S; Öneç K; Gönül II; Güz G
    Ren Fail; 2012; 34(10):1341-3. PubMed ID: 23009197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathology of recurrent diseases in kidney allografts: membranous nephropathy and focal segmental glomerulosclerosis.
    Kowalewska J
    Curr Opin Organ Transplant; 2013 Jun; 18(3):313-8. PubMed ID: 23619512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors at de novo donor-specific antibody initial detection associated with allograft loss: a multicenter study.
    Schinstock CA; Dadhania DM; Everly MJ; Smith B; Gandhi M; Farkash E; Sharma VK; Samaniego-Picota M; Stegall MD
    Transpl Int; 2019 May; 32(5):502-515. PubMed ID: 30597643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrent and de novo glomerular disease after renal transplantation: a report from Renal Allograft Disease Registry (RADR).
    Hariharan S; Adams MB; Brennan DC; Davis CL; First MR; Johnson CP; Ouseph R; Peddi VR; Pelz CJ; Roza AM; Vincenti F; George V
    Transplantation; 1999 Sep; 68(5):635-41. PubMed ID: 10507481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.